Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
3/31/2026
IMPACT Therapeutics Renews Hong Kong IPO Push With Updated Filing
3/31/2026
Syneron Bio Closes Major Series B to Advance AI-Driven Macrocyclic Pep...
3/31/2026
Biocytogen Licenses RenNano® Antibody Discovery Platform to Taisho Ph...
3/31/2026
NHSA Deepens Dialogue With MNC Pharma on Innovation Drug Value and Rea...
3/31/2026
NMPA Moves to Strengthen China's Conditional Drug Approval Framework
3/31/2026
CK Life Sciences Moves to Fast-Track China Cancer Vaccine Development ...
3/31/2026
Huahui Launches World's First Approved Hepatitis D Antibody Drug in Ch...
3/31/2026
Connect Biopharma Reports Promising Late-Stage China Results for Eczem...
3/31/2026
Braveheart Bio Posts Promising Mid-Stage China Data for HCM Drug Licen...
3/31/2026
China's Innovative Drug Out-Licensing Nears Half of 2025 Total in Firs...
3/31/2026
Santen Accelerates China Strategy by Moving Earlier Into Global Ophtha...
3/31/2026
Innovent Publishes Strong Phase II Mazdutide 9 mg Obesity Data as Chin...
3/31/2026
Simcere Highlights Late-Breaking Phase III Success for Rademikibart in...
3/30/2026
NMPA Releases 103rd Batch of Generic Drug Reference Formulations Catal...
3/30/2026
Dizal Reports Strong First-Line ELCC 2026 Data for ZEGFROVY in Uncommo...
3/30/2026
Enhertu Wins First Global Approval in Neoadjuvant HER2-Positive Early ...
3/30/2026
BioRay and UCB Win Dual China Dermatology Approvals for Bimzelx
3/30/2026
China Approves Claruvis's Retoxin, Marking New Milestone in Recombinan...
3/30/2026
Almirall Partners Shanghai Huaota in $340 Million Dermatology Antibody...
3/30/2026
AZ/Amgen's Tezspire Wins China Approval for Asthma and CRSwNP
3/30/2026
GSK's Exdensur Wins China Approval for Severe Eosinophilic Asthma
3/30/2026
Abbisko Wins FDA Orphan Drug Designation for ABSK061 in Achondroplasia
3/30/2026
Kailera Files for IPO to Fund China-Licensed Obesity Pipeline
3/30/2026
Insilico Lands Landmark $2.75B Lilly Deal as AI Drug Discovery Momentu...
3/27/2026
Recent Executive Moves
3/27/2026
SK Biopharma Launches Epilepsy Drug Cenobamate in China
3/27/2026
GSK Partners Shanghai Pharma to Reintroduce Hepatitis B Vaccine in Chi...
3/27/2026
Jiangsu Aidea Targets Hong Kong IPO to Accelerate Global Expansion in ...
3/27/2026
China Pharma Market Set for Structural Shift as Innovation and Cost Pr...
3/27/2026
Insilico and Tenacia Expand AI-Driven Collaboration in CNS Drug Disco...
Page:
1
/
61
Total number of articles:
1822
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit